2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2020-6-1-0-71964Pharmacology<strong>Comprehensive assessment of using micronised purified flavonoid fraction in the correction of disorders associated with ADMA-like preeclampsia in experiment</strong><br /> &nbsp;<strong>Comprehensive assessment of using micronised purified flavonoid fraction in the correction of disorders associated with ADMA-like preeclampsia in experiment</strong><br /> &nbsp;AntsiferovaOksana E.AntsiferovaOksana E.AnciferovaO@ya.ruGureevVladimir V.GureevVladimir V.produmen@yandex.ruGureevaAnastasia V.GureevaAnastasia V.nastasyi.207@gmail.comAvdeevaElena V.AvdeevaElena V.avdeyeva_ev@mail.ruMikhailovaYulia A.MikhailovaYulia A.myil75@mail.ruKuzminDmitriy B.KuzminDmitriy B.dmitriy.kuzmin.79@bk.ru20206100

Background: About 10% of pregnancies in the world are accompanied by&nbsp;hypertensive disorders, while from 2 to 8% are preeclampsia. One of the components of the pathogenesis of preeclampsia is placental ischemia. The humoral factors released during preeclampsia have a pro-inflammatory effect and can contribute to the development of endothelial dysfunction. One of the possible options for reducing the effects of these cytokines may be the use of drugs containing natural flavonoids, one of the positive aspects of which is the reduction of venospecific inflammation. The aim of the study: To study the effectiveness of using purified micronized flavonoid fraction (diosmin+flavonoids expressed as hesperidin) in the correction of functional disorders that occur during preeclampsia in the experiment. Materials and methods: The experiment was performed on 100 white female rats of the Wistar line weighing 250-300 g. ADMA-like agent (L-NAME) was introduced intraperitoneally at a dose of 25 mg/kg/day from 14 to 20 days of gestation. The purified micronized flavonoid fraction (diosmin + flavonoids expressed as hesperidin) in dosages of 86 mg/kg and 260 mg/kg was administered orally once a day from 14 to 20 days of pregnancy. On the 21st day of pregnancy, functional tests and laboratory tests were performed. Results: The administration of purified micronized flavonoid fraction to laboratory animals leads to a pronounced correction of pathological changes in experimental ADMA-like preeclampsia with the greatest effect in a higher dose of the drug used. A significant decrease in systolic and diastolic pressure was noted, respectively, improved microcirculation in the placenta, restoration of the NO-synthesizing function of the endothelium, and a decrease in proteinuria. Conclusion: The results of the study indicate the promise of using a purified micronized flavonoid fraction for the correction of functional changes in preeclampsia and substantiate the feasibility of further research in this direction.

Background: About 10% of pregnancies in the world are accompanied by&nbsp;hypertensive disorders, while from 2 to 8% are preeclampsia. One of the components of the pathogenesis of preeclampsia is placental ischemia. The humoral factors released during preeclampsia have a pro-inflammatory effect and can contribute to the development of endothelial dysfunction. One of the possible options for reducing the effects of these cytokines may be the use of drugs containing natural flavonoids, one of the positive aspects of which is the reduction of venospecific inflammation. The aim of the study: To study the effectiveness of using purified micronized flavonoid fraction (diosmin+flavonoids expressed as hesperidin) in the correction of functional disorders that occur during preeclampsia in the experiment. Materials and methods: The experiment was performed on 100 white female rats of the Wistar line weighing 250-300 g. ADMA-like agent (L-NAME) was introduced intraperitoneally at a dose of 25 mg/kg/day from 14 to 20 days of gestation. The purified micronized flavonoid fraction (diosmin + flavonoids expressed as hesperidin) in dosages of 86 mg/kg and 260 mg/kg was administered orally once a day from 14 to 20 days of pregnancy. On the 21st day of pregnancy, functional tests and laboratory tests were performed. Results: The administration of purified micronized flavonoid fraction to laboratory animals leads to a pronounced correction of pathological changes in experimental ADMA-like preeclampsia with the greatest effect in a higher dose of the drug used. A significant decrease in systolic and diastolic pressure was noted, respectively, improved microcirculation in the placenta, restoration of the NO-synthesizing function of the endothelium, and a decrease in proteinuria. Conclusion: The results of the study indicate the promise of using a purified micronized flavonoid fraction for the correction of functional changes in preeclampsia and substantiate the feasibility of further research in this direction.

purified micronized flavonoid fractionpreeclampsiaendothelial dysfunctionratsproteinuriamicrocirculationpurified micronized flavonoid fractionpreeclampsiaendothelial dysfunctionratsproteinuriamicrocirculationСписок литературыGhulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012 Feb;36(1):56-9. DOI: https://doi.org/10.1053/j.semperi.2011.09.011Krasnyi AM, Gracheva MI, Sadekova AA, et al. Complex Analysis of Total and Fetal DNA and Cytokines in Blood Plasma of Pregnant Women with Preeclampsia. Bull Exp Biol Med. 2018 Apr 16;164:721-725. DOI: https://doi.org/10.1007/s10517-018-4066-1Das UN. Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia. Nutrition. 2015 Sep;31(9):1083-95. DOI: https://doi.org/10.1016/j.nut.2015.03.013Iriyama T, Wang W, Parchim NF, et al. Hypoxia-independent up regulation of placental hypoxia inducible factor 1 alpha gene expression contributes to the pathogenesis of preeclampsia. Hypertension 2015 Apr 6;65(6):1307-1315. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.115.05314Voronkov AV, Gamzeleva OY. [Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins]. Statsionarozameshchayushchiye tekhnologii: Ambulatornaya khirurgiya. 2019;(1-2):27-33. Russian. DOI: https://doi.org/10.21518/1995-1477-2019-1-2-27-33Lukyanova Y, Kolesnichenko P, Gureev V, et al. Evaluation of Pharmacological Correction of L-NAME-induced Endothelial Dysfunction, Platelet Aggregation and Venous Tone With Diosmin &quot;Detralex 1000 mg&quot;. Research Results in Pharmacology. 2018;4(4):1-7. DOI:&nbsp;https://doi.org/10.3897/rrpharmacology.4.31748Mansilha A, Sousa J. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int J Mol Sci. 2018 Jun 5;19(6):E1669. DOI: https://doi.org/10.3390/ijms19061669Patel K, Gadewar M, Tahilyani V, et al. A review on pharmacological and analytical aspects of diosmetin: a concise report. Chin J Integr Med. 2013 Oct;19(10):792-800. DOI: 10.1007/s11655-013-1595-3Ali TM, Abo-Salem OM, Esawy BH, et al. The Potential Protective Effects of Diosmin on Streptozotocin-Induced Diabetic Cardiomyopathy in Rats. Am J Med Sci. 2020 Jan;359(1):32-41. DOI: 10.1016/j.amjms.2019.10.005Chitra J, Yacoob SAM, Kumar SS, et al. HPLC characterization, acute and sub-acute toxicity evaluation of bark extract of Rhizophora mucronata in Swiss Albino mice. Heliyon. 2019 Dec 31;6(1):e03108. DOI: 10.1016/j.heliyon.2019.e03108Hilary S, Tom&aacute;s-Barber&aacute;n FA, Martinez-Blazquez JA, et al. Polyphenol characterisation of Phoenix dactylifera L. (date) seeds using HPLC-mass spectrometry and its bioaccessibility using simulated in-vitro digestion/Caco-2 culture model. Food Chem. 2020 May 1;311:125969. DOI: 10.1016/j.foodchem.2019.125969Klimek-Szczykutowicz M, Szopa A, Ekiert H. Citrus limon (Lemon) Phenomenon-A Review of the Chemistry, Pharmacological Properties, Applications in the Modern Pharmaceutical, Food, and Cosmetics Industries, and Biotechnological Studies. Plants (Basel). 2020 Jan 17;9(1):E119. DOI: 10.3390/plants9010119Medina-Torres N, Espinosa-Andrews H, Trombotto S, et al. Ultrasound-Assisted Extraction Optimization of Phenolic Compounds from Citrus latifolia Waste for Chitosan Bioactive Nanoparticles Development. Molecules. 2019 Sep 30;24(19):E3541. DOI: 10.3390/molecules24193541Curr&ograve; D. The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues. Expert Rev Clin Pharmacol. 2018 Feb;11(2):171-183. DOI: 10.1080/17512433.2018.1414598Chen X, Xu L, Guo S, et al. Profiling and comparison of the metabolites of diosmetin and diosmin in rat urine, plasma and feces using UHPLC-LTQ-Orbitrap MSn. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Aug 15;1124:58-71. DOI: 10.1016/j.jchromb.2019.05.030Li X, Hu X, Wang J, et al. Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia/reperfusion injury. International Journal of Molecular Medicine. 2018;42(4):1917-1924. DOI: https://doi.org/10.3892/ijmm.2018.3794Elhelaly AE, AlBasher G, Alfarraj S, et al. Protective effects of hesperidin and diosmin against acrylamide-induced liver, kidney, and brain oxidative damage in rats. Environ Sci Pollut Res Int. 2019 Dec;26(34):35151-35162. DOI: 10.1007/s11356-019-06660-3Sl&iacute;va J. Diosmin &ndash; still an important modality in the treatment of venous insufficiency. Vnitr Lek. 2019 Jan 1;65(7-8):524-526.Lichota A, Gwozdzinski L, Gwozdzinski K. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. Eur J Med Chem. 2019 Aug 15;176:68-91. DOI: 10.1016/j.ejmech.2019.04.075Akhmetzianov RV, Bredikhin RA. Clinical efficacy of Detralex in treatment of women with pelvic varicose veins. Angiol Sosud Khir. 2018 Jan 1;24(2):93-99.Rodnyansky DV, Fokin AA. Diosmin-containing phlebotropic drugs in varicose eczema. Angiol Sosud Khir. 2019;25(3):88-92. DOI: 10.33529/ANGI02019303Feldo M, Woźniak M, W&oacute;jciak-Kosior M, et al. Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency. Oxid Med Cell Longev. 2018 Aug 28;2018:2561705. DOI: 10.1155/2018/2561705Zagriadskiĭ EA, Bogomazov AM, Golovko EB. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study. Adv Ther. 2018 Nov;35(11):1979-1992. DOI: 10.1007/s12325-018-0794-xCorsale I, Carrieri P, Martellucci J, et al. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study. Int J Colorectal Dis. 2018 Nov;33(11):1595-1600. DOI: 10.1007/s00384-018-3102-yBashankaev BN, Wexner SD, Arkharov AV. Common sense of diosmin administration in combined treatment of hemorrhoids. Khirurgiia (Mosk). 2018 Jan 1;(8. Vyp. 2):83-89. DOI: 10.17116/hirurgia201808283Cacchio A, Di Carlo G, Vincenza C, et al. Effectiveness and safety of a mixture of diosmin, coumarin and arbutin (Linfadren&reg;) in addition to conventional treatment in the management of patients with post-trauma/surgery persistent hand edema: a randomized controlled trial. Clin Rehabil. 2019 May;33(5):904-912. DOI: 10.1177/0269215519829797Cacchio A, Prencipe R, Bertone M, et al. Effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren&reg;) in addition to complex decongestive therapy on management of breast cancer-related lymphedema. Support Care Cancer. 2019 Apr;27(4):1471-1480. DOI: 10.1007/s00520-018-4514-5Zudin AM, Gritsenko AG, Hadzhishvili IT. The effects of diosmin and hesperidin on capillary blood flow of upper limbs in patients with secondary Raynaud&#39;s syndrome. Khirurgiia (Mosk). 2017;5:60-66. DOI: 10.17116/hirurgia2017560-66Feldo M, W&oacute;jciak-Kosior M, Sowa I, et al. Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis. Molecules. 2019 Sep 12;24(18):E3316. DOI: 10.3390/molecules24183316Wojnar W, Kaczmarczyk-Sedlak I, Zych M. Diosmin ameliorates the effects of oxidative stress in lenses of streptozotocin-induced type 1 diabetic rats. Pharmacol Rep. 2017 Oct;69(5):995-1000. DOI: 10.1016/j.pharep.2017.04.005Atia NM, Hazzah HA, Gaafar PME, et al. Diosmin Nanocrystal-Loaded Wafers for Treatment of Diabetic Ulcer: In Vitro and In Vivo Evaluation. J Pharm Sci. 2019 May;108(5):1857-1871. DOI: 10.1016/j.xphs.2018.12.019Jain D, Bansal MK, Dalvi R, et al. Protective effect of diosmin against diabetic neuropathy in experimental rats. J Integr Med. 2014 Jan;12(1):35-41. DOI: 10.1016/S2095-4964(14)60001-7Liu WY, Liou SS, Hong TY, et al. The Benefits of the Citrus Flavonoid Diosmin on Human Retinal Pigment Epithelial Cells under High-Glucose Conditions. Molecules. 2017 Dec 18;22(12):E2251. DOI: 10.3390/molecules22122251Ahmed S, Mundhe N, Borgohain M, et al. Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy. Inflammation. 2016 Oct;39(5):1783-97. DOI: 10.1007/s10753-016-0413-4Hsu CC, Lin MH, Cheng JT, et al. Diosmin, a Citrus Nutrient, Activates Imidazoline Receptors to Alleviate Blood Glucose and Lipids in Type 1-Like Diabetic Rats. Nutrients. 2017 Jun 30;9(7):E684. DOI: 10.3390/nu9070684Hsu CC, Lin MH, Cheng JT, et al. Antihyperglycaemic action of diosmin, a citrus flavonoid, is induced through endogenous &beta;-endorphin in type I-like diabetic rats. Clin Exp Pharmacol Physiol. 2017 May;44(5):549-555. DOI: 10.1111/1440-1681.12739El-Fawal R, El Fayoumi HM, Mahmoud MF. Effects of diosmin and crocin on metabolic syndrome-associated cardio-vascular complications in rats. Naunyn Schmiedebergs Arch Pharmacol. 2019 Dec;392(12):1523-1536. DOI: 10.1007/s00210-019-01700-8El-Fawal R, El Fayoumi HM, Mahmoud MF. Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: Effect on oxidative stress and low grade inflammation. Biomed Pharmacother. 2018 Jun;102:930-937. DOI: 10.1016/j.biopha.2018.03.162Abd ElHady WE, Mohamed EA, Soliman OAE, et al. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Int J Nanomedicine. 2019 Sep 4;14:7191-7213. DOI: 10.2147/IJN.S213836Shalkami AS, Hassan M, Bakr AG. Anti-inflammatory, antioxidant and anti-apoptotic activity of diosmin in acetic acid-induced ulcerative colitis. Hum Exp Toxicol. 2018 Jan;37(1):78-86. DOI: 10.1177/0960327117694075Li T, Zhu W, Liu G, et al. Diosmin for the prevention of ovarian hyperstimulation syndrome. Int J Gynaecol Obstet [Internet]. 2020 Jan 10 [cited 2020 January 20]. Available from: https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1002/ijgo.13100 DOI: 10.1002/ijgo.13100Yarmolinsky L, Budovsky A, Yarmolinsky L, et al. Effect of Bioactive Phytochemicals from Phlomis viscosa Poiret on Wound Healing. Plants (Basel). 2019 Dec 16;8(12):E609. DOI: 10.3390/plants8120609Shabani S, Mirshekar MA. Diosmin is neuroprotective in a rat model of scopolamine-induced cognitive impairment. Biomed Pharmacother. 2018 Dec;108:1376-1383. DOI: 10.1016/j.biopha.2018.09.127Mirshekar MA, Fanaei H, Keikhaei F, et al. Diosmin improved cognitive deficit and amplified brain electrical activity in the rat model of traumatic brain injury. Biomed Pharmacother. 2017 Sep;93:1220-1229. DOI: 10.1016/j.biopha.2017.07.014Wang Y, Fang X, Ye L, et al. A Randomized Controlled Trial Evaluating the Effects of Diosmin in the Treatment of Radicular Pain. Biomed Res Int. 2017;2017:6875968. DOI: 10.1155/2017/6875968Carballo-Villalobos AI, Gonz&aacute;lez-Trujano ME, Pellicer F, et al. Central and peripheral anti-hyperalgesic effects of&nbsp;diosmin in a neuropathic pain model in rats. Biomed Pharmacother. 2018 Jan;97:310-320. DOI: 10.1016/j.biopha.2017.10.077Ali FEM, Bakr AG, Abo-Youssef AM, et al. Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis. Life Sci. 2018 Aug 15;207:50-60. DOI: 10.1016/j.lfs.2018.05.048Gelle P, Crepin G, Delahousse G. Varices in pregnancy. Use of Daflon. Lille Med. 1972 Nov;17(7):1466-8.Muller P, Wolff F, Schick RA, et al. The interest and prospects of Daflon treatment in obstetrical and gynaecological practice. Rev Fr Gynecol Obstet. 1973 May;68(5):345-9.Buckshee K, Takkar D, Aggarwal N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet. 1997 May;57(2):145-51.Milchev N, Batashki I, Markova D, et al. Using phlebodia in pregnant women during preterm delivery. Akush Ginekol (Sofiia). 2008;47(5):7-9.Lakhno IV. Pathogenetic percularities of fetal distress in pregnant women with preeclampsia. Georgian Med News. 2013 Oct;223:11-6.Lacroix I, Beau AB, Hurault-Delarue C, et al. First epidemiological data for venotonics in pregnancy from the EFEMERIS database. Phlebology. 2016 Jun;31(5):344-8. DOI: 10.1177/0268355515589679Polish Gynecological Society. Recommendations of the Polish Gynecological Society expert panel on the use of Detramax in pregnancy. Ginekol Pol. 2015 Dec;86(12):962-5.Antsiferova OE, Yurakova AV, Lokteva TI, et al. [Comprehensive assessment of the correction of morphofunctional disorders in ADMA preeclampsia by trimetazidine]. Vestnik Smolenskoy gosudarstvennoy meditsinskoy akademii. 2019;18(1):103-108. Russian.Gureev V. New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental Preeclampsia. Research Results in Pharmacology. 2016;2(3):11-27. DOI: https://doi.org/10.18413/2500-235X-2016-2-3-11-27Shaban NZ, Zahran AMA, El-Rashidy FH, et al. Protective role of hesperidin against &gamma;-radiation-induced oxidative stress and apoptosis in rat testis. Journal of Biological Research-Thessaloniki. 2017;24:5. DOI: https://doi.org/10.1186/s40709-017-0059-xLin JT, Chang YY, Chen YC, et al. Molecular mechanisms of the effects of the ethanolic extract of Muntingia calabura Linn. fruit on lipopolysaccharide-induced pro-inflammatory mediators in macrophages. Food Funct. 2017 Mar 22;8(3):1245-1253. DOI: 10.1039/c6fo01735eBerkoz M. Diosmin suppresses the proinflammatory mediators in lipopolysaccharide-induced RAW264.7 macrophages via NF-&kappa;B and MAPKs signal pathways. Gen Physiol Biophys. 2019 Jul;38(4):315-324. DOI: 10.4149/gpb_2019010Michiels C, Arnould T, Houbion A, et al. A comparative study of the protective effect of different phlebotonic agents on endothelial cells in hypoxia. Phlebologie. 1991 Jul-Oct;44(3):779-86.Paredes MD, Romec&iacute;n P, Atucha NM, et al. Moderate Effect of Flavonoids on Vascular and Renal Function in Spontaneously Hypertensive Rats. Nutrients. 2018 Aug 16;10(8):E1107. DOI: 10.3390/nu10081107Paredes MD, Romec&iacute;n P, Atucha NM, et al. Beneficial Effects of Different Flavonoids on Vascular and Renal Function in L-NAME Hypertensive Rats. Nutrients. 2018 Apr 13;10(4):E484. DOI: 10.3390/nu10040484Ma Y, Tan F, Yu S. Diosmin inhibits apoptosis of vascular endothelial cells in rats with traumatic deep vein thrombosis through JAK-STAT signaling pathway. Panminerva Med [Internet]. 2019 Sep 24 [cited 2020 January 20]. Available from: https://www.minervamedica.it/en/journals/panminerva-medica/article.php?cod=R41Y9999N00A19092403 DOI: 10.23736/S0031-0808.19.03718-2Kalinin RE, Suchkov IA, Kamaev AA, et al. Endotheliotropic effects of venotonic drugs in treatment of patients with varicose veins. Angiol Sosud Khir. 2018 Jan 1;24(4):72-74.Gurfinkel&#39; II, Sasonko ML, Talov NA. Correction of blood microcirculation parameters and endothelial function in chronic venous insufficiency of lower limbs. Angiol Sosud Khir. 2017 Jan 1;23(2):89-95.Liu X, Zhang X, Zhang J, et al. Diosmin protects against cerebral ischemia/reperfusion injury through activating JAK2/STAT3 signal pathway in mice. Neuroscience. 2014 May 30;268:318-27. DOI: 10.1016/j.neuroscience.2014.03.032Kilicoglu SS, Tanrikulu Y, Kismet K, et al. The effect of diosmin on pancreatic injury induced by hepatic ischemia reperfusion in rats. Bratisl Lek Listy. 2013 Jan 1;114(3):119-24.Mastantuono T, Battiloro L, Sabatino L, et al. Effects of Citrus Flavonoids Against Microvascular Damage Induced by Hypoperfusion and Reperfusion in Rat Pial Circulation. Microcirculation. 2015 Jul;22(5):378-90. DOI: 10.1111/micc.12207